IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CGCT

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q4 2023
Cash & Equivalents112.8325.450.000.000.0041.7248.25--
Total Current Assets115.600.5132.890.830.96--49.64--
Property, Plant & Equipment19.2220.2121.28------47.69--
Total Non-current Assets*27.05285.8829.89280.74277.86--66.40--
Total Assets142.65286.3962.78281.56278.820.71116.03--
Accounts Payable0.720.660.74------0.47--
Total Current Liabilities6.601.390.830.400.420.744.42--
Total Non-current Liabilities*51.0613.1413.1413.1413.140.0018.46--
Total Liabilities*57.6614.5313.9713.5413.560.7422.88--
Retained Earnings(275.49)(14.01)(255.58)(12.65)(12.51)(0.06)(181.73)--
Total Stockholder Equity85.00(14.01)(221.39)(12.65)(12.51)(0.04)(0.02)(111.25)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Research & Development6.581.94------6.75
Selling, General & Admin6.380.810.550.140.450.02
Total Operating Expenses12.96----------
Operating Income(12.96)(0.81)(0.55)(0.14)(0.45)(13.12)
Pretax Income(11.34)(8.57)------(12.87)
Tax Provision0.000.000.000.000.000.00
Net Income(11.34)1.682.162.761.32(12.87)
Basic EPS(0.61)(1.70)------(2.57)
Diluted EPS(0.85)(1.70)------(2.57)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Operating Cash Flow(11.16)(0.23)(0.04)(0.17)(0.30)(6.10)
Capital Expenditures0.560.48------0.17
Free Cash Flow*(11.72)(0.71)------(6.27)
Investing Cash Flow(0.58)(0.49)0.000.00(276.00)(0.17)
Financing Cash Flow96.093.300.000.00277.13(0.20)
← Scroll for more columns →

* Derived from reported values